-
1
-
-
85039629952
-
Popularity of herbs; sprouts from publicity
-
July 13
-
Hemlich N. Popularity of herbs; sprouts from publicity. USA Today. July 13, 1998.
-
(1998)
USA Today
-
-
Hemlich, N.1
-
3
-
-
0031747773
-
St John's wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy
-
Laakman G, Schule C, Baghai T, Kieser M. St John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 1998; 31(suppl 1):54-59.
-
(1998)
Pharmacopsychiatry
, vol.31
, Issue.SUPPL. 1
, pp. 54-59
-
-
Laakman, G.1
Schule, C.2
Baghai, T.3
Kieser, M.4
-
4
-
-
0030874985
-
Biologically active and other chemical constituents of the herb Hypericum perforatum
-
Narstedt A, Butterweck V. Biologically active and other chemical constituents of the herb Hypericum perforatum. Pharmacopsychiatry 1997; 30:129-134.
-
(1997)
Pharmacopsychiatry
, vol.30
, pp. 129-134
-
-
Narstedt, A.1
Butterweck, V.2
-
5
-
-
0031748869
-
Antidepressant efficacy of Hypericum perforatum and hyperforin: The neglected possibility
-
Chaterjee SS, Nolder M, Koch E, Erdelmeier C. Antidepressant efficacy of Hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry 1998; 31(suppl 1):7-15.
-
(1998)
Pharmacopsychiatry
, vol.31
, Issue.SUPPL. 1
, pp. 7-15
-
-
Chaterjee, S.S.1
Nolder, M.2
Koch, E.3
Erdelmeier, C.4
-
6
-
-
0031780096
-
Hyperforin represents the neurotransmitter reuptake-inhibiting constituent of hypericum extract
-
Muller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schafer C. Hyperforin represents the neurotransmitter reuptake-inhibiting constituent of hypericum extract. Pharmacopsychiatry 1998; 31(suppl 1):16-21.
-
(1998)
Pharmacopsychiatry
, vol.31
, Issue.SUPPL. 1
, pp. 16-21
-
-
Muller, W.E.1
Singer, A.2
Wonnemann, M.3
Hafner, U.4
Rolli, M.5
Schafer, C.6
-
7
-
-
0033596554
-
Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes
-
Neary JT, Bu Y. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res 1999; 816:358-363.
-
(1999)
Brain Res.
, vol.816
, pp. 358-363
-
-
Neary, J.T.1
Bu, Y.2
-
8
-
-
0032788651
-
Neuroendocrine evidence of dopaminergic actions of hypericum extract (LI 160) in healthy volunteers
-
Franklin M, Chi J, Hockney R, et al. Neuroendocrine evidence of dopaminergic actions of hypericum extract (LI 160) in healthy volunteers. Biol Psychiatry 1999; 46:581-584.
-
(1999)
Biol. Psychiatry
, vol.46
, pp. 581-584
-
-
Franklin, M.1
Chi, J.2
Hockney, R.3
-
9
-
-
0030881089
-
In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract
-
Cott JM. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiatry 1997; 30(suppl 1):108-112.
-
(1997)
Pharmacopsychiatry
, vol.30
, Issue.SUPPL. 1
, pp. 108-112
-
-
Cott, J.M.1
-
10
-
-
0030768989
-
Effect of long-term administration of hypericin extracts on the affinity of the central serotonergic 5HT1A and 5HT2A receptors
-
Teufel-Mayer R, Gleitz J. Effect of long-term administration of hypericin extracts on the affinity of the central serotonergic 5HT1A and 5HT2A receptors. Pharmacopsychiatry 1997; 30(suppl):113-116.
-
(1997)
Pharmacopsychiatry
, vol.30
, Issue.SUPPL.
, pp. 113-116
-
-
Teufel-Mayer, R.1
Gleitz, J.2
-
12
-
-
0037051930
-
Effect of Hypericum perforatum (St John's Wort) in major depressive disorder
-
Hypericum Depression Trial Study Group
-
Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John's Wort) in major depressive disorder. JAMA 2002; 287:1807-1814.
-
(2002)
JAMA
, vol.287
, pp. 1807-1814
-
-
-
13
-
-
0035906295
-
Effectiveness of St John's wort in major depression: A randomized controlled trial
-
Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA 2001; 285:1978-1986.
-
(2001)
JAMA
, vol.285
, pp. 1978-1986
-
-
Shelton, R.C.1
Keller, M.B.2
Gelenberg, A.3
-
14
-
-
0033547613
-
Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomized multicenter study of treatment for eight weeks
-
Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomized multicenter study of treatment for eight weeks. BMJ 1999; 319:1534-1538.
-
(1999)
BMJ
, vol.319
, pp. 1534-1538
-
-
Philipp, M.1
Kohnen, R.2
Hiller, K.O.3
-
16
-
-
0034707701
-
St John's wort for depression: A systematic review
-
Gaster B, Holroyd J. St John's wort for depression: a systematic review. Arch Intern Med 2000; 160:152-156.
-
(2000)
Arch. Intern. Med.
, vol.160
, pp. 152-156
-
-
Gaster, B.1
Holroyd, J.2
-
17
-
-
0034008572
-
Equivalence of St. John's wort extract (ZE 117) and fluoxetine
-
for the Study Group
-
Shrader E, for the Study Group. Equivalence of St. John's wort extract (ZE 117) and fluoxetine. Int Clin Psychopharmacol 2000; 15:61-68.
-
(2000)
Int. Clin. Psychopharmacol.
, vol.15
, pp. 61-68
-
-
Shrader, E.1
-
18
-
-
0033389387
-
Hypericum for depression. An update of the clinical evidence
-
Stevinson C, Ernst E. Hypericum for depression. An update of the clinical evidence. Eur Neuropsychopharmacol 1999; 9:501-505.
-
(1999)
Eur. Neuropsychopharmacol.
, vol.9
, pp. 501-505
-
-
Stevinson, C.1
Ernst, E.2
-
19
-
-
0036334488
-
Efficacy of St. John's wort extract WS 5570 in major depression: A double-blind, placebo-controlled trial
-
Lecrubier Y, Clerc G, Didi R, Kieser M. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 2002; 159:1361-1366.
-
(2002)
Am. J. Psychiatry
, vol.159
, pp. 1361-1366
-
-
Lecrubier, Y.1
Clerc, G.2
Didi, R.3
Kieser, M.4
-
21
-
-
0141611906
-
Effect of St. John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme
-
Markowitz JS, Donovan JL, DeVane L, et al. Effect of St. John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003; 290:1500-1504.
-
(2003)
JAMA
, vol.290
, pp. 1500-1504
-
-
Markowitz, J.S.1
Donovan, J.L.2
DeVane, L.3
-
22
-
-
0003686749
-
-
Editor. Boca Raton, Fla: CRC Press, Inc
-
McGuffin M, editor. Botanical Safety Handbook. Boca Raton, Fla: CRC Press, Inc., 1997:62-63.
-
(1997)
Botanical Safety Handbook
, pp. 62-63
-
-
McGuffin, M.1
-
23
-
-
0037151365
-
Effects of St. John's wort on irinotecan metabolism
-
Mathijssen R, Verweij J, de Bruijn P, Loos WJ, Sparreboom A. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 2002; 94:1247-1249.
-
(2002)
J. Natl. Cancer Inst.
, vol.94
, pp. 1247-1249
-
-
Mathijssen, R.1
Verweij, J.2
de Bruijn, P.3
Loos, W.J.4
Sparreboom, A.5
-
24
-
-
0037151372
-
St. John's wort: More complications for cancer patients
-
(editorial)
-
Mansky P, Straus S. St. John's wort: more complications for cancer patients (editorial). J Natl Cancer Inst 2002; 94:1187-1188.
-
(2002)
J. Natl. Cancer Inst.
, vol.94
, pp. 1187-1188
-
-
Mansky, P.1
Straus, S.2
-
26
-
-
0345290651
-
Complementary and alternative treatments in psychiatry
-
Tasman A, Kay J, Lieberman JA, editors. Second Edition. Southern Gate, West Sussex, England: John Wiley and Sons, Ltd
-
Brown RP, Gerbarg PL, Muskin PR. Complementary and alternative treatments in psychiatry. In: Tasman A, Kay J, Lieberman JA, editors. Psychiatry Therapeutics, Second Edition. Southern Gate, West Sussex, England: John Wiley and Sons, Ltd, 2003:449-485.
-
(2003)
Psychiatry Therapeutics
, pp. 449-485
-
-
Brown, R.P.1
Gerbarg, P.L.2
Muskin, P.R.3
-
27
-
-
0034835244
-
A systematic review and meta-analysis of Hypericum perforatum in depression: A comprehensive clinical review
-
Whiskey E, Werneke U, Taylor D. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. Int Clin Psychopharmacol 2001; 16:239-252.
-
(2001)
Int. Clin. Psychopharmacol.
, vol.16
, pp. 239-252
-
-
Whiskey, E.1
Werneke, U.2
Taylor, D.3
-
28
-
-
0036139750
-
The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava
-
Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 2002; 136:42-53.
-
(2002)
Ann. Intern. Med.
, vol.136
, pp. 42-53
-
-
Ernst, E.1
-
29
-
-
0037108649
-
Ethical considerations of complementary and alternative therapies in conventional medical settings
-
Adams KE, Cohen MH, Eisenberg D, Jonsen AR. Ethical considerations of complementary and alternative therapies in conventional medical settings. Ann Intern Med 2002; 137:660-664
-
(2002)
Ann. Intern. Med.
, vol.137
, pp. 660-664
-
-
Adams, K.E.1
Cohen, M.H.2
Eisenberg, D.3
Jonsen, A.R.4
|